Stay Ahead in Fast-Growing Economies.
Browse Reports Now
Peripheral Neuropathy Treatment Market Size, Share, Growth & Forecast (2024-2032)
Peripheral Neuropathy Treatment Market Size Was Valued at USD 1,796.8 Million in 2023, and is Projected to Reach USD 2,535.4 Million by 2032, Growing at a CAGR of 3.9% From 2024-2032.
IMR Group
Description
Peripheral Neuropathy Treatment Market Synopsis:
Peripheral Neuropathy Treatment Market Size Was Valued at USD 1,796.8 Million in 2023, and is Projected to Reach USD 2,535.4 Million by 2032, Growing at a CAGR of 3.9% From 2024-2032.
Peripheral neuropathy is a disease affecting the peripheral nerves which causes weakness, burning, tingling and numbness often in the arms and legs. Peripherally, management of peripheral neuropathy included drugs, physical therapy, operations, amongst other procedures like Transcutaneous Electrical Nerve Stimulation abbreviated TENS. The demand for the treatment of peripheral neuropathy is increasing because the diseases that cause neuropathy are also on the rise such as diabetes and chemotherapy.
The market for pharmacological and non-pharmacological peripheral neuropathy treatment has exhibited progressive growth in the past few years due to increase in diabetic neuropathy cases, extension in the geriatric population susceptible to nerve disorders. Research conducted earlier approximates that about twenty million people of Americans have peripheral neuropathy of some type. Also the increased awareness of the value of timely diagnosis due to improved diagnostic tools, treatments also augment this sector’s expansion. Technological treatment includes routine drugs, modern drugs, psychotherapies, biofeedback therapy, cognitive behaviour therapies, physiotherapy, occupational therapy, speech pathology, anesthetic therapies and all other procedures which serve to help the patient cope with the symptoms and enhance his quality of life.
The available treatment options, for peripheral neuropathy are very many. These include analgesics, antiepileptics, and antidepressants because medications are mostly used in the treatment of neuropathic pain. Moreover, it used to enhance the strength and motor function of those patients who have motor function disorder. In more severe cases, surgery is the definitive method of treatment, although more non-invasive methods have been developed and widely used, including TENS therapy. Continuous innovations in medical sciences and inventions of fresh therapies shall add on the effectiveness of the cure. In addition, the shift to more target-based therapy where treatment is prescribed depending on the patient’s state, which right now is a growing tendency in this market.
Peripheral Neuropathy Treatment Market Trend Analysis:
Growing Preference for Non-Invasive Treatments
Non-invasive treatments for peripheral neuropathy are becoming more popular because they are safer and usually feel better for patient. Pain management products including TENS (Transcutaneous Electrical Nerve Stimulation) are improving and being used by patients and healthcare systems. TENS involves the application of low voltage electric currents in order to reduce or eliminate pain by messing up the nerves. It is popular because patients may administer it themselves at their house thus avoiding to many visits to hospitals and they feel they have charge over their treatment process. TENS is particularly preferred by people who suffer from peripheral neuropathy that is a chronic pain condition because of its side effects are far much fewer as compared to those of drugs.
The emergence of more sophisticated wearable apparatus using electrical stimulation technology provides the patient with a method of pain relief that is non-intrusive and far more effective. These devices are convenient and can be taken at home by the patient. This is also expected to enhance the use of such treatments considering that the use of digital health and remote patient monitoring systems is also expected to grow as well. TENS devices and other non-invasive products will remain relevant in the peripheral neuropathy treatment market because patients’ preferences are increasingly shifting towards at-home remedies with smaller risks.
Rising Adoption of Personalized Medicine
One broad opportunity in the peripheral neuropathy treatment market is the growing concept of personalised medication. Individualised therapies are prescribed with reference to the specific individual’s genetic profile, their life history and their environment thus, are more effective than generalised treatments. As medical science progresses in genomic arena and bio-technology, the clinicians can find out the real factors affecting peripheral neuropathy in their patients and prescribe the respective therapies. This is particularly important in such diagnoses as diabetic neuropathy, since the cause of the disease in different patients may be radically different.
When using highly individualized approaches in managing the patient’s treatment, the clinician would be able to address the patients’ pain more effectively, lessen the intensity of neuropathy’s manifestations and forestall the further evolution of the disease. In addition, it is possible to reduce certain risks which accompany side effects of universally applied remedies, with the help of individual directed cures. While much of the current research is focusing on genetic biomarkers and precision medicine the need for tailored neuropathy treatments is expected to increase and will generate more opportunities for pharmaceutical and biotechnology markets. It would mean better management of peripheral neuropathy that would enhance better outcomes in the field and increase the size of the market.
Peripheral Neuropathy Treatment Market Segment Analysis:
Peripheral Neuropathy Treatment Market is Segmented on the basis of Treatment Type, Drug Class, Disease Type, Distribution Channel, End User, and Region.
By Treatment Type, Medications segment is expected to dominate the market during the forecast period
The medications segment has the largest share of peripheral neuropathy treatment market mainly due to the increasing need for pain management. Neuropathic pain is the most severe symptom of which anticonvulsants and antidepressants are mainly used to treat. However, physical therapy is the most well-established approaches to treatment and it can be applied to patients with motor function disorder. With increasing consciousness about the requirement of physical rehabilitation, physical therapy is slowly and gradually becoming a part of integral treatment. It is also emerging popular among patients owing to the fact that it is non-invasive, and is equally effective in treating chronic pain, as is offered under the TENS therapy.
Although pharmaceuticals persist as the primary treatment method, there is increasing concern in non-pharmacological approaches. TENS therapy is rapidly growing in popularity for patients who need something different from drugs as it has fewer side effects and can be provided at home. In view of the fact that many patients are now shifting to seek non-pharmacological modalities to address their symptoms, the use and shipment of TENS devices as well as other solutions should experience a boost in the same manner. Although surgery is also effective especially in severe cases, it is not a frequently used method because of commitment of largely invasive procedures and high costs of surgeries.
By End User, Hospitals segment expected to held the largest share
At the moment, more players operating in a treatment market belong to hospitals since they provide full-spectrum care and have the corresponding infrastructure to work with complicated cases. The sophisticated and expensive treatments such as surgery, chemotherapy, radiation therapy and other expensive treatments are normally provided in hospitals. Notably, clinic and outpatient centers are also important point of care for peripheral neuropathy, especially for checkups or non-surgical procedures and physical therapy. Clinics are likely to provide individualized services and also admits patients to receive treatments that can be treated as outpatient cases.
The home care segment is on the rise because patients are able to control their condition with prescribed medication or with such tools as TENS unit. Due to the elements of patients’ demand for convenience and flexibility, home care settings have been an essential part of the treatment. These settings make treatment easier and cheaper since patients can deal with their symptoms more often through approaches other than admission to a hospital.
Peripheral Neuropathy Treatment Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
North America is identified as the largest market for peripheral neuropathy treatment owing to the high incidence of diseases such as diabetes. The region also has a good health care systems; people are well aware of the condition; and research in the field has been well funded. countries, especially in the United States, neuropathies are becoming increasingly more common and as a result, the need for optimal remedies also rises. This sector is also the base for many top pharmaceutical and medical device companies that create additional business for the market.
North America enjoys adequate healthcare provision that includes existence of technologies such as physical therapy, TENS devices and health enhancing medications. High levels of exploring in this region on health care guarantee that the patients avail the best of the current treatments. Furthermore, the rising demand for better quality or prolonged life of life for chronic diseases such as diabetes and Chemotherapy induced neuropathies is expected to support North America’s continuous dominance over this market.
Active Key Players in the Peripheral Neuropathy Treatment Market:
Pfizer Inc. (USA)
Novartis International AG (Switzerland)
Eli Lilly and Company (USA)
Johnson & Johnson (USA)
Amgen Inc. (USA)
Bayer AG (Germany)
Teva Pharmaceutical Industries Ltd. (Israel)
Merck & Co., Inc. (USA)
Sanofi S.A. (France)
AbbVie Inc. (USA)
Grünenthal GmbH (Germany)
Mylan N.V. (USA)
Other Active Players
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter’s Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Peripheral Neuropathy Treatment Market by Product Type
4.1 Peripheral Neuropathy Treatment Market Snapshot and Growth Engine
4.2 Peripheral Neuropathy Treatment Market Overview
4.3 Head Protection
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Head Protection: Geographic Segmentation Analysis
4.4 Eye & Face Protection
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Eye & Face Protection: Geographic Segmentation Analysis
4.5 Hearing Protection
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Hearing Protection: Geographic Segmentation Analysis
4.6 Protective Clothing
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Protective Clothing: Geographic Segmentation Analysis
4.7 Respiratory Protection
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Respiratory Protection: Geographic Segmentation Analysis
4.8 Hand & Arm Protection
4.8.1 Introduction and Market Overview
4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.8.3 Key Market Trends, Growth Factors and Opportunities
4.8.4 Hand & Arm Protection: Geographic Segmentation Analysis
4.9 Foot & Leg Protection
4.9.1 Introduction and Market Overview
4.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.9.3 Key Market Trends, Growth Factors and Opportunities
4.9.4 Foot & Leg Protection: Geographic Segmentation Analysis
4.10 Fall Protection
4.10.1 Introduction and Market Overview
4.10.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.10.3 Key Market Trends, Growth Factors and Opportunities
4.10.4 Fall Protection: Geographic Segmentation Analysis
Chapter 5: Peripheral Neuropathy Treatment Market by End-User Industry
5.1 Peripheral Neuropathy Treatment Market Snapshot and Growth Engine
5.2 Peripheral Neuropathy Treatment Market Overview
5.3 Healthcare
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Healthcare: Geographic Segmentation Analysis
5.4 Construction
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Construction: Geographic Segmentation Analysis
5.5 Manufacturing
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Manufacturing: Geographic Segmentation Analysis
5.6 Oil & Gas
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Oil & Gas: Geographic Segmentation Analysis
5.7 Chemical
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Chemical: Geographic Segmentation Analysis
5.8 Mining
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Mining: Geographic Segmentation Analysis
5.9 Firefighting
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.9.3 Key Market Trends, Growth Factors and Opportunities
5.9.4 Firefighting: Geographic Segmentation Analysis
5.10 Pharmaceuticals
5.10.1 Introduction and Market Overview
5.10.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.10.3 Key Market Trends, Growth Factors and Opportunities
5.10.4 Pharmaceuticals: Geographic Segmentation Analysis
5.11 Food & Beverage
5.11.1 Introduction and Market Overview
5.11.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.11.3 Key Market Trends, Growth Factors and Opportunities
5.11.4 Food & Beverage: Geographic Segmentation Analysis
5.12 Automotive
5.12.1 Introduction and Market Overview
5.12.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.12.3 Key Market Trends, Growth Factors and Opportunities
5.12.4 Automotive: Geographic Segmentation Analysis
Chapter 6: Peripheral Neuropathy Treatment Market by Application
6.1 Peripheral Neuropathy Treatment Market Snapshot and Growth Engine
6.2 Peripheral Neuropathy Treatment Market Overview
6.3 Industrial
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Industrial: Geographic Segmentation Analysis
6.4 Healthcare & Medical
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Healthcare & Medical: Geographic Segmentation Analysis
6.5 Household
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Household: Geographic Segmentation Analysis
Chapter 7: Peripheral Neuropathy Treatment Market by Distribution Channel
7.1 Peripheral Neuropathy Treatment Market Snapshot and Growth Engine
7.2 Peripheral Neuropathy Treatment Market Overview
7.3 Online
7.3.1 Introduction and Market Overview
7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.3.3 Key Market Trends, Growth Factors and Opportunities
7.3.4 Online: Geographic Segmentation Analysis
7.4 Offline
7.4.1 Introduction and Market Overview
7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.4.3 Key Market Trends, Growth Factors and Opportunities
7.4.4 Offline: Geographic Segmentation Analysis
Chapter 8: Company Profiles and Competitive Analysis
8.1 Competitive Landscape
8.1.1 Competitive Benchmarking
8.1.2 Peripheral Neuropathy Treatment Market Share by Manufacturer (2023)
8.1.3 Industry BCG Matrix
8.1.4 Heat Map Analysis
8.1.5 Mergers and Acquisitions
8.2 PFIZER INC. (USA)
8.2.1 Company Overview
8.2.2 Key Executives
8.2.3 Company Snapshot
8.2.4 Role of the Company in the Market
8.2.5 Sustainability and Social Responsibility
8.2.6 Operating Business Segments
8.2.7 Product Portfolio
8.2.8 Business Performance
8.2.9 Key Strategic Moves and Recent Developments
8.2.10 SWOT Analysis
8.3 NOVARTIS INTERNATIONAL AG (SWITZERLAND)
8.4 ELI LILLY AND COMPANY (USA)
8.5 JOHNSON & JOHNSON (USA)
8.6 AMGEN INC. (USA)
8.7 BAYER AG (GERMANY)
8.8 TEVA PHARMACEUTICAL INDUSTRIES LTD. (ISRAEL)
8.9 MERCK & CO. INC. (USA)
8.10 SANOFI S.A. (FRANCE)
8.11 ABBVIE INC. (USA)
8.12 GRÜNENTHAL GMBH (GERMANY)
8.13 MYLAN N.V. (USA)
8.14 OTHER ACTIVE PLAYERS
Chapter 9: Global Peripheral Neuropathy Treatment Market By Region
9.1 Overview
9.2. North America Peripheral Neuropathy Treatment Market
9.2.1 Key Market Trends, Growth Factors and Opportunities
9.2.2 Top Key Companies
9.2.3 Historic and Forecasted Market Size by Segments
9.2.4 Historic and Forecasted Market Size By Product Type
9.2.4.1 Head Protection
9.2.4.2 Eye & Face Protection
9.2.4.3 Hearing Protection
9.2.4.4 Protective Clothing
9.2.4.5 Respiratory Protection
9.2.4.6 Hand & Arm Protection
9.2.4.7 Foot & Leg Protection
9.2.4.8 Fall Protection
9.2.5 Historic and Forecasted Market Size By End-User Industry
9.2.5.1 Healthcare
9.2.5.2 Construction
9.2.5.3 Manufacturing
9.2.5.4 Oil & Gas
9.2.5.5 Chemical
9.2.5.6 Mining
9.2.5.7 Firefighting
9.2.5.8 Pharmaceuticals
9.2.5.9 Food & Beverage
9.2.5.10 Automotive
9.2.6 Historic and Forecasted Market Size By Application
9.2.6.1 Industrial
9.2.6.2 Healthcare & Medical
9.2.6.3 Household
9.2.7 Historic and Forecasted Market Size By Distribution Channel
9.2.7.1 Online
9.2.7.2 Offline
9.2.8 Historic and Forecast Market Size by Country
9.2.8.1 US
9.2.8.2 Canada
9.2.8.3 Mexico
9.3. Eastern Europe Peripheral Neuropathy Treatment Market
9.3.1 Key Market Trends, Growth Factors and Opportunities
9.3.2 Top Key Companies
9.3.3 Historic and Forecasted Market Size by Segments
9.3.4 Historic and Forecasted Market Size By Product Type
9.3.4.1 Head Protection
9.3.4.2 Eye & Face Protection
9.3.4.3 Hearing Protection
9.3.4.4 Protective Clothing
9.3.4.5 Respiratory Protection
9.3.4.6 Hand & Arm Protection
9.3.4.7 Foot & Leg Protection
9.3.4.8 Fall Protection
9.3.5 Historic and Forecasted Market Size By End-User Industry
9.3.5.1 Healthcare
9.3.5.2 Construction
9.3.5.3 Manufacturing
9.3.5.4 Oil & Gas
9.3.5.5 Chemical
9.3.5.6 Mining
9.3.5.7 Firefighting
9.3.5.8 Pharmaceuticals
9.3.5.9 Food & Beverage
9.3.5.10 Automotive
9.3.6 Historic and Forecasted Market Size By Application
9.3.6.1 Industrial
9.3.6.2 Healthcare & Medical
9.3.6.3 Household
9.3.7 Historic and Forecasted Market Size By Distribution Channel
9.3.7.1 Online
9.3.7.2 Offline
9.3.8 Historic and Forecast Market Size by Country
9.3.8.1 Russia
9.3.8.2 Bulgaria
9.3.8.3 The Czech Republic
9.3.8.4 Hungary
9.3.8.5 Poland
9.3.8.6 Romania
9.3.8.7 Rest of Eastern Europe
9.4. Western Europe Peripheral Neuropathy Treatment Market
9.4.1 Key Market Trends, Growth Factors and Opportunities
9.4.2 Top Key Companies
9.4.3 Historic and Forecasted Market Size by Segments
9.4.4 Historic and Forecasted Market Size By Product Type
9.4.4.1 Head Protection
9.4.4.2 Eye & Face Protection
9.4.4.3 Hearing Protection
9.4.4.4 Protective Clothing
9.4.4.5 Respiratory Protection
9.4.4.6 Hand & Arm Protection
9.4.4.7 Foot & Leg Protection
9.4.4.8 Fall Protection
9.4.5 Historic and Forecasted Market Size By End-User Industry
9.4.5.1 Healthcare
9.4.5.2 Construction
9.4.5.3 Manufacturing
9.4.5.4 Oil & Gas
9.4.5.5 Chemical
9.4.5.6 Mining
9.4.5.7 Firefighting
9.4.5.8 Pharmaceuticals
9.4.5.9 Food & Beverage
9.4.5.10 Automotive
9.4.6 Historic and Forecasted Market Size By Application
9.4.6.1 Industrial
9.4.6.2 Healthcare & Medical
9.4.6.3 Household
9.4.7 Historic and Forecasted Market Size By Distribution Channel
9.4.7.1 Online
9.4.7.2 Offline
9.4.8 Historic and Forecast Market Size by Country
9.4.8.1 Germany
9.4.8.2 UK
9.4.8.3 France
9.4.8.4 The Netherlands
9.4.8.5 Italy
9.4.8.6 Spain
9.4.8.7 Rest of Western Europe
9.5. Asia Pacific Peripheral Neuropathy Treatment Market
9.5.1 Key Market Trends, Growth Factors and Opportunities
9.5.2 Top Key Companies
9.5.3 Historic and Forecasted Market Size by Segments
9.5.4 Historic and Forecasted Market Size By Product Type
9.5.4.1 Head Protection
9.5.4.2 Eye & Face Protection
9.5.4.3 Hearing Protection
9.5.4.4 Protective Clothing
9.5.4.5 Respiratory Protection
9.5.4.6 Hand & Arm Protection
9.5.4.7 Foot & Leg Protection
9.5.4.8 Fall Protection
9.5.5 Historic and Forecasted Market Size By End-User Industry
9.5.5.1 Healthcare
9.5.5.2 Construction
9.5.5.3 Manufacturing
9.5.5.4 Oil & Gas
9.5.5.5 Chemical
9.5.5.6 Mining
9.5.5.7 Firefighting
9.5.5.8 Pharmaceuticals
9.5.5.9 Food & Beverage
9.5.5.10 Automotive
9.5.6 Historic and Forecasted Market Size By Application
9.5.6.1 Industrial
9.5.6.2 Healthcare & Medical
9.5.6.3 Household
9.5.7 Historic and Forecasted Market Size By Distribution Channel
9.5.7.1 Online
9.5.7.2 Offline
9.5.8 Historic and Forecast Market Size by Country
9.5.8.1 China
9.5.8.2 India
9.5.8.3 Japan
9.5.8.4 South Korea
9.5.8.5 Malaysia
9.5.8.6 Thailand
9.5.8.7 Vietnam
9.5.8.8 The Philippines
9.5.8.9 Australia
9.5.8.10 New Zealand
9.5.8.11 Rest of APAC
9.6. Middle East & Africa Peripheral Neuropathy Treatment Market
9.6.1 Key Market Trends, Growth Factors and Opportunities
9.6.2 Top Key Companies
9.6.3 Historic and Forecasted Market Size by Segments
9.6.4 Historic and Forecasted Market Size By Product Type
9.6.4.1 Head Protection
9.6.4.2 Eye & Face Protection
9.6.4.3 Hearing Protection
9.6.4.4 Protective Clothing
9.6.4.5 Respiratory Protection
9.6.4.6 Hand & Arm Protection
9.6.4.7 Foot & Leg Protection
9.6.4.8 Fall Protection
9.6.5 Historic and Forecasted Market Size By End-User Industry
9.6.5.1 Healthcare
9.6.5.2 Construction
9.6.5.3 Manufacturing
9.6.5.4 Oil & Gas
9.6.5.5 Chemical
9.6.5.6 Mining
9.6.5.7 Firefighting
9.6.5.8 Pharmaceuticals
9.6.5.9 Food & Beverage
9.6.5.10 Automotive
9.6.6 Historic and Forecasted Market Size By Application
9.6.6.1 Industrial
9.6.6.2 Healthcare & Medical
9.6.6.3 Household
9.6.7 Historic and Forecasted Market Size By Distribution Channel
9.6.7.1 Online
9.6.7.2 Offline
9.6.8 Historic and Forecast Market Size by Country
9.6.8.1 Turkiye
9.6.8.2 Bahrain
9.6.8.3 Kuwait
9.6.8.4 Saudi Arabia
9.6.8.5 Qatar
9.6.8.6 UAE
9.6.8.7 Israel
9.6.8.8 South Africa
9.7. South America Peripheral Neuropathy Treatment Market
9.7.1 Key Market Trends, Growth Factors and Opportunities
9.7.2 Top Key Companies
9.7.3 Historic and Forecasted Market Size by Segments
9.7.4 Historic and Forecasted Market Size By Product Type
9.7.4.1 Head Protection
9.7.4.2 Eye & Face Protection
9.7.4.3 Hearing Protection
9.7.4.4 Protective Clothing
9.7.4.5 Respiratory Protection
9.7.4.6 Hand & Arm Protection
9.7.4.7 Foot & Leg Protection
9.7.4.8 Fall Protection
9.7.5 Historic and Forecasted Market Size By End-User Industry
9.7.5.1 Healthcare
9.7.5.2 Construction
9.7.5.3 Manufacturing
9.7.5.4 Oil & Gas
9.7.5.5 Chemical
9.7.5.6 Mining
9.7.5.7 Firefighting
9.7.5.8 Pharmaceuticals
9.7.5.9 Food & Beverage
9.7.5.10 Automotive
9.7.6 Historic and Forecasted Market Size By Application
9.7.6.1 Industrial
9.7.6.2 Healthcare & Medical
9.7.6.3 Household
9.7.7 Historic and Forecasted Market Size By Distribution Channel
9.7.7.1 Online
9.7.7.2 Offline
9.7.8 Historic and Forecast Market Size by Country
9.7.8.1 Brazil
9.7.8.2 Argentina
9.7.8.3 Rest of SA
Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies
Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research
Q1: What would be the forecast period in the Peripheral Neuropathy Treatment Market research report?
A1: The forecast period in the Peripheral Neuropathy Treatment Market research report is 2024-2032.
Q2: Who are the key players in the Peripheral Neuropathy Treatment Market?
A2: Pfizer Inc. (USA), Novartis International AG (Switzerland), Eli Lilly and Company (USA), Johnson & Johnson (USA), Amgen Inc. (USA), Bayer AG (Germany), Teva Pharmaceutical Industries Ltd. (Israel), Merck & Co., Inc. (USA), Sanofi S.A. (France), AbbVie Inc. (USA), Grünenthal GmbH (Germany), Mylan N.V. (USA), and Other Active Players.
Q3: What are the segments of the Peripheral Neuropathy Treatment Market?
A3: The Peripheral Neuropathy Treatment Market is segmented into Treatment Type, Drug Class, Disease Type, Distribution Channel, End User and Region. By Treatment Type, the market is categorized into Medications, Physical Therapy, Surgery, Transcutaneous Electrical Nerve Stimulation (TENS), Others. By Drug Class, the market is categorized into Antidepressants, Anticonvulsants, Pain Relievers, Topical Treatments, Others. By Disease Type, the market is categorized into Diabetic Neuropathy, Chemotherapy-Induced Neuropathy, Alcoholic Neuropathy, Idiopathic Neuropathy, Hereditary Neuropathy, Others. By Distribution Channel, the market is categorized into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others. By End-User, the market is categorized into Hospitals, Clinics, Home Care Settings, Others. By region, it is analyzed across North America (U.S., Canada, Mexico), Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe), Western Europe (Germany, UK, France, Netherlands, Italy, Spain, Rest of Western Europe), Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New Zealand, Rest of APAC), Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa), South America (Brazil, Argentina, Rest of SA).
Q4: What is the Peripheral Neuropathy Treatment Market?
A4: Peripheral neuropathy is a disease affecting the peripheral nerves which causes weakness, burning, tingling and numbness often in the arms and legs. Peripherally, management of peripheral neuropathy included drugs, physical therapy, operations, amongst other procedures like Transcutaneous Electrical Nerve Stimulation abbreviated TENS. The demand for the treatment of peripheral neuropathy is increasing because the diseases that cause neuropathy are also on the rise such as diabetes and chemotherapy.
Q5: How big is the Peripheral Neuropathy Treatment Market?
A5: Peripheral Neuropathy Treatment Market Size Was Valued at USD 1,796.8 Million in 2023, and is Projected to Reach USD 2,535.4 Million by 2032, Growing at a CAGR of 3.9% From 2024-2032.
How to Buy a Report from eminsights.jp
On the product page, choose the license you want: Single-User License, Multi-User License or Enterprise License.
If you required report in your native language, then you can click on Translated Report button and fill out the form with report name and language you want, then our team will contact you as soon as possible.
Click the Buy Now button.
You will be redirected to the checkout page. Enter your company details and payment information.
Click Place Order to complete the purchase.
Confirmation: You’ll receive an order confirmation and our team will contact you shortly with your ordered report.
If you have any questions, fill out the contact form below or email us at bizdev@eminsights.net.
Thank you for choosing eminsights.jp!
